EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $824,160 | +12.0% | 37,719 | -2.1% | 0.05% | +23.8% |
| Q2 2023 | $736,098 | -52.4% | 38,519 | -51.7% | 0.04% | -52.3% |
| Q1 2023 | $1,547,016 | +27.2% | 79,702 | +5.1% | 0.09% | +25.7% |
| Q4 2022 | $1,216,041 | -5.4% | 75,813 | -7.5% | 0.07% | -6.7% |
| Q3 2022 | $1,286,000 | -29.5% | 81,991 | -6.4% | 0.08% | -14.8% |
| Q2 2022 | $1,824,000 | -7.8% | 87,586 | +0.3% | 0.09% | +11.4% |
| Q1 2022 | $1,979,000 | +18.1% | 87,298 | -4.8% | 0.08% | +33.9% |
| Q4 2021 | $1,675,000 | -13.6% | 91,653 | 0.0% | 0.06% | -18.1% |
| Q3 2021 | $1,938,000 | +12.8% | 91,653 | -2.8% | 0.07% | +18.0% |
| Q2 2021 | $1,718,000 | -23.5% | 94,299 | -5.1% | 0.06% | -16.4% |
| Q1 2021 | $2,245,000 | +6.4% | 99,399 | -5.4% | 0.07% | -1.4% |
| Q4 2020 | $2,109,000 | -28.6% | 105,099 | -13.0% | 0.07% | -37.8% |
| Q3 2020 | $2,952,000 | -2.3% | 120,748 | -5.1% | 0.12% | -8.5% |
| Q2 2020 | $3,021,000 | +35.1% | 127,272 | -2.0% | 0.13% | +4.0% |
| Q1 2020 | $2,236,000 | +4.0% | 129,869 | +6.5% | 0.12% | +71.2% |
| Q4 2019 | $2,149,000 | +34.0% | 121,944 | +34.4% | 0.07% | +28.1% |
| Q3 2019 | $1,604,000 | – | 90,716 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |